Data / Form D filings / ADAPTIN BIO, INC.
ADAPTIN BIO, INC.: Form D filing
ADAPTIN BIO, INC., a biotechnology company in Charlotte, NC, filed a Form D with the SEC in 2026. The latest, on January 5, 2026, reports $1 million sold of a $4 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3540 TORINGDON WAY SUITE 200, #250, Charlotte, NC, 28277
- Phone
- (888) 609-1498
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1938571
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5 | New notice | $4,000,000 | $1,000,000 | $3,000,000 | 7 | Dec 22 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Roberts | Executive Officer, Director | President and Chief Executive Officer |
| Patrick Gallagher | Director | |
| J. Nick Riehle | Director | |
| Anthony Zook | Director | |
| L. Arthur Hewitt | Executive Officer | Chief Development Officer |
| Timothy Maness | Executive Officer | Chief Financial Officer |
| Simon Pedder | Executive Officer, Director | Executive Chairman |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6
Every Form D from the week of Jan 5 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ADAPTIN BIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.